Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"13,407 (7,911, 21,631)","75.1% (64.3%, 87.5%)","68.9% (57.0%, 79.9%)","15.0% (12.0%, 21.8%)","72.0% (60.7%, 84.9%)","18.8 (16.1, 21.9)","17.2 (14.2, 20.0)","3.8 (3.0, 5.5)","18.0 (15.2, 21.2)",,,,,
"(p=None, None), q=(None, None), c=0.500)","10,454 (6,320, 17,295)","85.0% (71.6%, 96.3%)","56.1% (41.5%, 71.0%)","11.8% (8.7%, 16.1%)","82.2% (68.5%, 95.0%)","21.2 (17.9, 24.1)","14.0 (10.4, 17.7)","3.0 (2.2, 4.0)","20.6 (17.1, 23.8)","-21.3% (-45.6%, -10.3%)","13.3% (7.3%, 26.9%)","-19.0% (-32.3%, -6.7%)","-19.8% (-47.1%, 6.6%)","14.4% (7.6%, 28.4%)"
"(p=None, None), q=(None, None), c=0.750)","10,851 (6,822, 16,904)","84.6% (70.0%, 96.6%)","54.6% (41.2%, 70.3%)","11.3% (8.5%, 14.4%)","82.0% (67.1%, 95.5%)","21.2 (17.5, 24.2)","13.6 (10.3, 17.6)","2.8 (2.1, 3.6)","20.5 (16.8, 23.9)","-18.6% (-36.0%, -6.1%)","12.8% (5.9%, 22.5%)","-21.1% (-35.0%, -7.9%)","-23.4% (-48.4%, -5.2%)","14.0% (6.2%, 23.9%)"
"(p=None, None), q=(None, None), c=1.000)","10,945 (6,959, 16,852)","85.1% (72.5%, 97.0%)","53.9% (40.4%, 69.9%)","10.9% (8.1%, 14.2%)","82.5% (69.3%, 96.0%)","21.3 (18.1, 24.2)","13.5 (10.1, 17.5)","2.7 (2.0, 3.5)","20.6 (17.3, 24.0)","-17.1% (-37.8%, -6.4%)","13.5% (6.5%, 25.4%)","-22.0% (-35.6%, -8.6%)","-25.8% (-50.5%, -8.5%)","14.9% (6.9%, 27.1%)"
